Skip to content
Pulse Platform

Zimbabwe Rejects ‘Unbalanced’ US Healthcare Assistance Agreement Due to Information Concerns

Health funding illustration
The offered US funding was intended for programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has turned down a major American health deal worth $367m (£272m) over five years over Washington's demand for confidential data.

This move was revealed following a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".

A government spokesman later clarified that the US was requesting biological samples for research and commercial purposes while was unwilling to share the benefits from any future medical innovations.

"We must now begin the difficult and regrettable task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.

A medical body in Zimbabwe has called for more negotiations to secure a agreement agreeable to all parties so the country's vital HIV treatment initiative can be sustained.

Broader Background

This development comes after a comparable situation in neighbouring Kenya, where a high court blocked a similar health funding agreement after legal challenges were filed about the safety of Kenyans' medical information.

Since returning to office recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

The agency had managed aid for the American government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and responsibility.

Based on reports, Sixteen African countries have so far agreed to these new agreements, constituting over $18.3bn in committed funds.

Details of the Declined Deal

The money for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this cooperation might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through American-funded programmes," Tremont said.

However, official spokesman Nick Mangwana maintained the arrangement was "unfair".

"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, with no corresponding promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.

"In essence, our country would supply the basic resources for medical research without any certainty that the end products would be accessible to our population should a future disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the global health body and its pursuit of one-on-one deals were disrupting structures already set up through the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.

"This system is designed to ensure that when a country provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to develop them."

These objections over the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We welcome continued dialogue with our US partners on how subsequent co-operation might be structured in a manner that honours the sovereignty and dignity of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but recommended that negotiations need to persist given that a large portion of the country's Aids initiatives depended on external financing.

"Where specific concerns arise, such as those relating to information security or implementation frameworks, these can frequently be resolved through technical clarification and negotiated safeguards," the group said.

The halted deal underscores the continuing challenges between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly interconnected world.

About the author

Christopher Johnson

A digital strategist with over a decade of experience in tech marketing, specializing in data-driven campaigns and brand storytelling.

Pulse Platform

Type to search articles.